EUVIMEDObjevte EUVIMED
Crossref

A Chemogenetic System for Spatiotemporal Perturbation of Cellular Methylation Potential

Shusuke Ogihara, Yuuta Fujikawa, Ayaka Fujieda, Shio Horiuchi, Rika Kasai, Fumika Hatano, Taiki Ogura, Ryosuke Kojima iD, Isshin Shiiba, Hideshi Inoue, Yoshio Hayashi iD, Yasuteru Urano iD and 1 more

ACS Chemical Biology · 2026

DOI: 10.1021/acschembio.6c00548 ↗

At a glance

Journal article in ACS Chemical Biology, 2026. Written by Shusuke Ogihara and 12 co-authors. Institution: Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo113-0033, Japan. Major MEDLINE topics: S-Adenosylmethionine, Methyltransferases. 24 references. Funded by: Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science and Technology, Precursory Research for Embryonic Science and Technology.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

We developed a genetically encoded system to perturb the methylation potential of living cells by exploiting the metabolic consumption of S-adenosylmethionine (SAM) through a plant methyltransferase, eugenol O-methyltransferase 1 (EOMT1). This system enables control of intracellular SAM levels with spatio- and temporal precision, regulated by the expression of EOMT1 and the timing of eugenol addition. EOMT1 expression allowed concentration-dependent reduction of SAM levels within 30 min. The system revealed distinct histone marks such as H3K4me3, H3K9me3, and H3K27me3, which responded differentially to SAM perturbation, revealing variable sensitivity between histone methyltransferases and demethylases. In addition, the spatially restricted expression of EOMT1 enabled the metabolic link of SAM between multiple organelles.

Subjects

MeSH terms (MEDLINE)

S-AdenosylmethionineMethyltransferasesMethylationChemogeneticsHistones

Author keywords

S-adenosylmethionine (SAM)chemogenetic approachmethylationmethyltransferase

Substances

S-AdenosylmethionineMethyltransferasesHistones

Authors and institutions

  • Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo113-0033, Japan.
  • School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji-shi, Tokyo192-0392, Japan.
  • Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo113-0033, Japan.
  • Department of Life Science, Faculty of Science, Gakushuin University, Mejiro-ku, Tokyo171-8588, Japan.

ORCID profiles: Ryosuke Kojima, Yoshio Hayashi, Yasuteru Urano, Toru Komatsu

Funding

  • Japan Agency for Medical Research and Development
  • Ministry of Education, Culture, Sports, Science and Technology
  • Precursory Research for Embryonic Science and Technology
  • Fusion Oriented REsearch for disruptive Science and Technology
  • Naito Foundation
  • Hoansha Foundation
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • University of Tokyo

Cite

APA

Ogihara, S., Fujikawa, Y., Fujieda, A., Horiuchi, S., Kasai, R., Hatano, F., Ogura, T., Kojima, R., Shiiba, I., Inoue, H., Hayashi, Y., Urano, Y., & Komatsu, T. (2026). A Chemogenetic System for Spatiotemporal Perturbation of Cellular Methylation Potential. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00548

Vancouver

Ogihara S, Fujikawa Y, Fujieda A, Horiuchi S, Kasai R, Hatano F, et al. A Chemogenetic System for Spatiotemporal Perturbation of Cellular Methylation Potential. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00548

BibTeX
@article{Ogihara2026,
  author = {Ogihara, Shusuke and Fujikawa, Yuuta and Fujieda, Ayaka and Horiuchi, Shio and Kasai, Rika and Hatano, Fumika and Ogura, Taiki and Kojima, Ryosuke and Shiiba, Isshin and Inoue, Hideshi and Hayashi, Yoshio and Urano, Yasuteru and Komatsu, Toru},
  title = {A Chemogenetic System for Spatiotemporal Perturbation of Cellular Methylation Potential},
  journal = {ACS Chemical Biology},
  year = {2026},
  doi = {10.1021/acschembio.6c00548}
}
Start for free →